Shares of Eris Lifesciences and HEG gained by 1.45% and 6.38% respectively at 10:30 IST on BSE after Vanguard Group purchased bulk shares of these companies through open market transactions on Friday, 16 March 2018.
Eris Lifesciences (up 1.45% at Rs 824) and HEG (up 6.38% at Rs 3,345.25) advanced.
However, shares of Capital First were down 0.73% at Rs 643.50. Vanguard Group bought 9.31 lakh shares of Capital First at Rs 648.65 per share in a bulk deal on the NSE on Friday, 16 March 2018. Capital First is a financial institution focused on providing debt financing to micro small and medium enterprises (MSME) and Indian consumers.
Meanwhile, the S&P BSE Sensex was down 39.21 points or 0.12% at 33,136.79.
Vanguard Group purchased 10.12 lakh shares of Eris Lifesciences at Rs 814.88 per share in a bulk deal on the NSE on Friday, 16 March 2018. Eris Lifesciences is one of the fastest growing companies within the chronic and acute categories of the Indian Branded Formulations market such as: cardiovascular; anti-diabetes; vitamins; gastroenterology and gynaecology.
Vanguard Group bought 4.72 lakh shares of HEG at Rs 3,152.52 per share in a bulk deal on the NSE on Friday, 16 March 2018. HEG is the leading manufacturer and exporter of graphite electrodes in India.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content